Trial Profile
Protocol HKT-500-US12: A randomized, multicenter, double-blind, single dose study of the analgesic properties of HKT-500 and placebo in subjects with pain caused by mild to moderate osteoarthritis of the knee
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Ketoprofen (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 11 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 18 Apr 2008 New trial record.